Abstract | BACKGROUND: RESULTS: Inhibition of RPN2 expression led to a reduction in CD63 glycosylation. In addition, the localization of CD63 was deregulated by knockdown of RPN2. Interestingly, multidrug resistance protein 1 (MDR1) localization was displaced from the cell surface in CD63-silenced cells. CD63 silencing reduced the chemoresistance and invasion ability of malignant breast cancer cells. Furthermore, the enrichment of CD63/MDR1-double positive cells was associated with lymph node metastasis. Taken together, these results indicated that high glycosylation of CD63 by RPN2 is implicated in clinical outcomes in breast cancer patients. CONCLUSIONS: These findings describe a novel and important function of RPN2-mediated CD63 glycosylation, which regulates MDR1 localization and cancer malignancy, including drug resistance and invasion.
|
Authors | Naoomi Tominaga, Keitaro Hagiwara, Nobuyoshi Kosaka, Kimi Honma, Hitoshi Nakagama, Takahiro Ochiya |
Journal | Molecular cancer
(Mol Cancer)
Vol. 13
Pg. 134
(May 31 2014)
ISSN: 1476-4598 [Electronic] England |
PMID | 24884960
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- CD63 protein, human
- Membrane Proteins
- Tetraspanin 30
- ribophorin
- Hexosyltransferases
- RPN2 protein, human
- Proteasome Endopeptidase Complex
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics)
- Adult
- Aged
- Breast Neoplasms
(genetics, pathology)
- Female
- Glycosylation
- Hexosyltransferases
- Humans
- Lymphatic Metastasis
(pathology)
- MCF-7 Cells
- Membrane Proteins
(administration & dosage)
- Middle Aged
- Neoplasm Staging
- Proteasome Endopeptidase Complex
(genetics, metabolism)
- Tetraspanin 30
(genetics, metabolism)
|